HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Mohammed F. Chowdhry Hunaid A. Vohra Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chowdhry, M. F. Articles by Galiñanes, M. Search for Related Content PubMed PubMed Citation Articles by Chowdhry, M. F. Articles by Galiñanes, M. Related Collections Myocardial infarction Myocardial protection

J Thorac Cardiovasc Surg 2007;134:124-131
© 2007 The American Association for Thoracic Surgery

Cardiopulmonary Support and Physiology

Diabetes increases apoptosis and necrosis in both ischemic and nonischemic human myocardium: Role of caspases and poly–adenosine diphosphate–ribose polymerase

Cardiac Surgery Unit, Department of Cardiovascular Sciences, Glenfield Hospital, University of Leicester, Leicester, UK.

Received for publication September 8, 2006; revisions received December 7, 2006; accepted for publication December 28, 2006.

^_* Address for reprints: Manuel Galiñanes, MD, PhD, FRCS, FECTS, Cardiac Surgery Unit, Department of Cardiovascular Sciences, University of Leicester, Glenfield Hospital, Groby Rd, Leicester, LE3 9QP UK. (Email: mg50{at}le.ac.uk).

Objectives: Diabetes is an important predictor of morbidity and mortality after cardiac surgery, but the reason is unclear. The aims of these studies, therefore, were to elucidate whether cell death is greater in ischemic and nonischemic diabetic human myocardium than in nondiabetic myocardium and to investigate the underlying mechanism.

Methods: The right atrial appendages (n = 8 per group) of patients without diabetes and patients with type 1 and 2 diabetes were subjected to 90 minutes of simulated ischemia and 120 minutes reoxygenation. Tissue injury was measured by the release of creatine kinase into the media, and cellular apoptosis and necrosis were assessed in tissue by the terminal transferase deoxyuridine triphosphate nick-end labeling assay and propidium iodide staining. Initiator and effector caspases activations were also measured.

Results: Apoptosis and necrosis were greater in the type 2 and type 1 diabetes groups than in the nondiabetes group both in fresh tissue and after simulated ischemia–reoxygenation. Activation of effector caspases was also higher in the diabetes groups than in the nondiabetes group after simulated ischemia–reoxygenation. Caspase-3 inhibition reduced apoptosis in all study groups without influencing necrosis; however, poly–adenosine diphosphate–ribose polymerase inhibition resulted in a similar reduction in apoptosis and in necrosis in all groups, whereas caspase-2 inhibition did not.

Conclusions: Diabetes increases both apoptosis and necrosis in human myocardium, both fresh and after being subjected to ischemia–reoxygenation, an effect that is mediated, at least in part, by caspase-3 and poly–adenosine diphosphate–ribose polymerase activation. These results may explain the increased cardiac-related morbidity and mortality associated with cardiac surgery in patients with diabetes.

This article has been cited by other articles:

				M. Meloni, B. Descamps, A. Caporali, L. Zentilin, I. Floris, M. Giacca, and C. Emanueli Nerve Growth Factor Gene Therapy Using Adeno-Associated Viral Vectors Prevents Cardiomyopathy in Type 1 Diabetic Mice Diabetes, January 1, 2012; 61(1): 229 - 240. [Abstract] [Full Text] [PDF]

				Y. Ma, Y. Liu, S. Liu, Y. Qu, R. Wang, C. Xia, H. Pei, K. Lian, T. Yin, X. Lu, et al. Dynamic alteration of adiponectin/adiponectin receptor expression and its impact on myocardial ischemia/reperfusion in type 1 diabetic mice Am J Physiol Endocrinol Metab, September 1, 2011; 301(3): E447 - E455. [Abstract] [Full Text] [PDF]

				E. J. Anderson, E. Rodriguez, C. A. Anderson, K. Thayne, W. R. Chitwood, and A. P. Kypson Increased propensity for cell death in diabetic human heart is mediated by mitochondrial-dependent pathways Am J Physiol Heart Circ Physiol, January 1, 2011; 300(1): H118 - H124. [Abstract] [Full Text] [PDF]

				A. Baraka and H. AbdelGawad Targeting Apoptosis in the Heart of Streptozotocin-Induced Diabetic Rats Journal of Cardiovascular Pharmacology and Therapeutics, June 1, 2010; 15(2): 175 - 181. [Abstract] [PDF]

				M. Baranowski, A. Blachnio-Zabielska, T. Hirnle, D. Harasiuk, K. Matlak, M. Knapp, P. Zabielski, and J. Gorski Myocardium of type 2 diabetic and obese patients is characterized by alterations in sphingolipid metabolic enzymes but not by accumulation of ceramide J. Lipid Res., January 1, 2010; 51(1): 74 - 80. [Abstract] [Full Text] [PDF]

				S. Nanda, S. Longo, S. P. Bhatt, J. Pamula, S. G. Sharma, and T. H Dale Stress cardiomyopathy - a unique presentation of diabetic ketoacidosis Ann Clin Biochem, May 1, 2009; 46(3): 257 - 260. [Abstract] [Full Text] [PDF]

				D. Landau, C. Chayat, N. Zucker, E. Golomb, C. Yagil, Y. Yagil, and Y. Segev Early blood pressure-independent cardiac changes in diabetic rats J. Endocrinol., April 1, 2008; 197(1): 75 - 83. [Abstract] [Full Text] [PDF]